Reshape, a Copenhagen-based biotech company and YC W21 alum, recently secured a $20M Series A funding round led by Astanor Ventures. The company, known for its AI-powered robotic imaging system, aims to revolutionize lab experiments by automating visual assays with the next generation of lab automation robots. This innovation is expected to accelerate research and development in the biotech sector, particularly in #infosec, #cybersecurity, #technology, and #news. Reshape's technology allows for the tracking of visual changes in lab experiments, facilitating global collaboration and enabling biotech companies to tackle significant challenges more efficiently. The funding will also support Reshape's expansion into the US market, marking a significant step in the company's growth and its mission to 'decode nature'.